Osteoclast lineage and function
- PMID: 18424258
- DOI: 10.1016/j.abb.2008.03.037
Osteoclast lineage and function
Abstract
Osteoclasts are members of the monocyte/macrophage lineage and are formed by cellular fusions from their mononuclear precursors. Their differentiation is regulated by a number of other cells and their products, especially by RANKL and M-CSF. The resorbing osteoclasts are polarized and show specific plasma membrane domains. Polarization and bone resorption need a continuous membrane trafficking and modulation of the cytoskeleton. The most characteristic feature of osteoclasts is their unique capacity to dissolve crystalline hydroxyapatite by targeted secretion of HCl into the extracellular resorption lacuna. Organic matrix is degraded by enzymes like cathepsin K and the degradation products are transcytosed through the cell for secretion. Dissolution of hydroxyapatite releases large amounts of soluble calcium, phosphate and bicarbonate. Removal of these ions apparently involves the vesicular pathways and direct ion transport via different ion exchangers, channels and pumps. Detailed molecular knowledge of osteoclast differentiation and function has helped us to identify several target molecules and develop specific treatments to inhibit pathological bone resorption in various skeletal diseases.
Similar articles
-
Intracellular membrane trafficking in bone resorbing osteoclasts.Microsc Res Tech. 2003 Aug 15;61(6):496-503. doi: 10.1002/jemt.10371. Microsc Res Tech. 2003. PMID: 12879417 Review.
-
Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.Bone. 2009 Apr;44(4):717-28. doi: 10.1016/j.bone.2008.11.019. Epub 2008 Dec 11. Bone. 2009. PMID: 19118660
-
How the osteoclast degrades bone.Bioessays. 1998 Oct;20(10):837-46. doi: 10.1002/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.0.CO;2-D. Bioessays. 1998. PMID: 9819571 Review.
-
Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.J Bone Miner Res. 2006 Jan;21(1):58-66. doi: 10.1359/JBMR.050905. Epub 2005 Sep 6. J Bone Miner Res. 2006. PMID: 16355274
-
[Osteoclasts in bone metabolism].Kaibogaku Zasshi. 1991 Aug;66(4):215-25. Kaibogaku Zasshi. 1991. PMID: 1759556 Review. Japanese.
Cited by
-
Spatial multiplexed immunofluorescence analysis reveals coordinated cellular networks associated with overall survival in metastatic osteosarcoma.Bone Res. 2024 Sep 27;12(1):55. doi: 10.1038/s41413-024-00359-z. Bone Res. 2024. PMID: 39333065 Free PMC article.
-
[Research progress in the mechanism of protein factors in regulating bone remodeling].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2019 Jan 15;33(1):115-123. doi: 10.7507/1002-1892.201808059. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2019. PMID: 30644271 Free PMC article. Review. Chinese.
-
Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression.PLoS One. 2013 Dec 10;8(12):e82453. doi: 10.1371/journal.pone.0082453. eCollection 2013. PLoS One. 2013. PMID: 24340030 Free PMC article. Clinical Trial.
-
Paracrine-mediated differentiation and activation of human haematopoietic osteoclast precursor cells by skin and gingival fibroblasts.Cell Prolif. 2011 Jun;44(3):264-73. doi: 10.1111/j.1365-2184.2011.00751.x. Cell Prolif. 2011. PMID: 21535267 Free PMC article.
-
Vav1 inhibits RANKL-induced osteoclast differentiation and bone resorption.BMB Rep. 2019 Nov;52(11):659-664. doi: 10.5483/BMBRep.2019.52.11.013. BMB Rep. 2019. PMID: 31072447 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
